Healthcare Industry News and Trends

The growth of the market is driven by factors such as the involvement of rare blood groups, rising number of transplant procedures, and rising prevalence of chronic diseases in the North America region. Whereas, risks associated with autotransfusion is likely to have a negative impact on the growth of the market in the coming years. The autotransfusion process involves the reinfusion of the patient's blood. Blood is collected from the peritoneal cavity or thorax region. The process can be carried out before surgery or during and after the surgery using the autotransfusion system. Medical procedures, like joint replacement, spinal surgeries, and cardiac, among others, require autotransfusion. It helps to reduce the risk of infection, and also it eliminates the problems and complications associated with the banking and administration of homologous donor blood. It helps to prevent the transmission of transfusion-related blood-borne diseases in patients. Register for a fre...

The growth of the market is driven by factors such as the fast growth of epinephrine technology market in Europe and the growing prevalence of anaphylaxis cases in the European region. Whereas, lack of availability of epinephrine drug is likely to have a negative impact on the growth of the market in the coming years. Anaphylaxis is a severe, life ‑ threatening allergic reaction characterized by symptoms such as skin redness and itching, swallowing and breathing difficulties, wheezing, rapid breathing rate (tachypnoea), accelerated heart rate (tachycardia), and falling blood pressure. It may involve multiple systems of human body. Anaphylaxis is caused by exposure to an allergen (foods, insect stings, or medicines) that is recognized as a non-self by a human body. Register for a free Trial today and gain instant*access @ Click Here Key Players Influencing the Market: Novartis AG Teva Pharmaceuticals Ltd. Mylan N.V. Amneal Pharmaceuticals LLC ALK-Abelló A/S Abb...

According to the new research report published by The Insight Partners, titled “ IoT in Healthcare Market - Global Analysis and Forecast to 2025”, the global IoT in healthcare market is expected to reach US$ 135.9 Bn in 2025, registering a CAGR of 21.2% during the forecast period 2017-2025. In 2025, North America is expected to account for more than one-third of total IoT in healthcare revenue market share. The growth is majorly driven by enhanced IoT infrastructure in the region with better connectivity, availability of skilled professionals and rising incidences of chronic diseases such as obesity, diabetes etc. Get PDF Sample Copy of this Report @ https://bit.ly/2ysjfNB Top Dominating Key Players: Koninklijke Philips N.V. Medtronic Plc Siemen Healthcare GmbH Proteus Digital Health, Inc. IBM Watson Health General Electric Healthcare Microsoft Corporation Qualcomm Life, Inc. STANLEY Healthcare Verily Life Sciences LLC (Alphabet-Google) ...

Cold Plasma is also called as non-thermal plasma and used in wide range of applications in various industries including medical and biomedical industries. It is a powerful tool which is used to provide antimicrobial treatment for wounds and injuries. The Cold Plasma Equipment technology offers non-thermal treatment of cancer, dentistry and others. Cold plasma is proven   effective in the biomedicine sector. Cold plasma is used in many medical treatments such as, atmospheric plasma on diabetes-induced enzyme glycation, oxidative stress, inflammation, disinfection, wound healing, cancer, dermatology, and scar treatment. Cold plasma have the ability to kill bacteria, including the drug-resistant bacteria to avoid further infection which helps in treating chronic wounds. Register for a free Trial today and gain instant*access @ Click Here Top Dominating Key Players: Henniker Plasma Nordson Corporation TheraDep Technologies Neoplas tools GmbH Plasmatreat GmbH ...

Prostate cancer is affecting the prostate glands in the male. Prostate cancer is a common cancer following skin cancer in the male. Some common determinants responsible for the start of prostate cancer are family history, old age, and race. Nuclear medicine is imaging that needs radioactive materials. It is a helpful method to identify and also treat prostate cancer and helps radiologists to conclude the stage of cancer. US prostate cancer nuclear medicine diagnostics market is driven by factors such as the rising prevalence of prostate cancer, and the growth of innovative radiopharmaceuticals plays a vital role in the growth of the radiopharmaceuticals market. However, strict guidelines for storage, production, & use of radiopharmaceuticals is likely to obstruct the growth of the US prostate cancer nuclear medicine diagnostics market during the forecast period. Register for a free Trial today and gain instant*access @ Click Here Top Dominating Key Players: B...

According to The Insight Partners market research study of ‘ Biodefense Market to 2027   – Global Analysis and Forecasts by Product.’ The global Biodefense market is expected to reach US$ 8,350.74 Mn in 2027 from US$ 4,108.24 Mn in 2019. The market is estimated to grow with a CAGR of 9.4% from 2020-2027. The report provides trends prevailing in the global biodefense market and the factors driving market along with those that act as hindrances. Key Players Influencing the Market:           Bavarian Nordic           Alnylam Pharmaceuticals, Inc.           SIGA Technologies           Emergent BioSolutions Inc.           Cleveland Bio Labs           Dynavax Technologies           Elusys Therapeutics, Inc.           Soligenix           Altimmune ...

The growth of US hemodynamic monitoring system is estimated due to the factors such as increasing product developments and approvals, rising cardiovascular disease prevalence, and growing geriatric population. On the other hand, the market is projected to experience slow growth due to risks associated with invasive hemodynamic monitoring systems. Advancements in medical technology and innovations, as well as increase in R&D spending by manufacturers, have resulted in the launch of various medical devices, including hemodynamic monitoring systems. At present, the hemodynamic monitoring systems are used to guide physicians to design the therapies or treatments at the time of circulatory instability for the patients living with cardiovascular diseases. Register for a free Trial today and gain instant*access @ Click Here Top Dominating Key Players:        General Electric Company         LIDCO         P...